Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Sarah Pirio Richardson & H. A. Jinnah. (2019) New approaches to discovering drugs that treat dystonia. Expert Opinion on Drug Discovery 14:9, pages 893-900.
Read now
Read now
Marco Mantero, Dejan Radovanovic, Pierachille Santus & Francesco Blasi. (2018) Management of severe COPD exacerbations: focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2319-2333.
Read now
Read now
Pierachille Santus, Dejan Radovanovic, Andrea Cristiano, Vincenzo Valenti & Maurizio Rizzi. (2017) Role of nebulized glycopyrrolate in the treatment of chronic obstructive pulmonary disease. Drug Design, Development and Therapy 11, pages 3257-3271.
Read now
Read now
Igor Z Barjaktarevic, Anthony F Arredondo & Christopher B Cooper. (2015) Positioning new pharmacotherapies for COPD. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 1427-1442.
Read now
Read now
Paul W Jones. (2015) Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 677-687.
Read now
Read now
Nobuyuki Horita & Takeshi Kaneko. (2015) Role of combined indacaterol and glycopyrronium bromide (QVA149) for the treatment of COPD in Japan. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 813-822.
Read now
Read now
Articles from other publishers (22)
A. G. Chuchalin, S. N. Avdeev, Z. R. Aisanov, A. S. Belevskiy, I. V. Leshchenko, S. I. OvcharenkoE. I. Shmelev. (2022) Federal guidelines on diagnosis and treatment of chronic obstructive pulmonary disease. PULMONOLOGIYA 32:3, pages 356-392.
Crossref
Crossref
Alberto Papi, Konstantinos Kostikas, Ivan Nikolaev & Ioannis Kottakis. (2022) Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A
Combination Therapy for Asthma. Current Respiratory Medicine Reviews 18:2, pages 77-85.
Crossref
Crossref
Yasuhito Suzuki, Suguru Sato, Kento Sato, Sumito Inoue & Yoko Shibata. (2022) Treatment efficacy of LAMA versus placebo for stable chronic obstructive pulmonary disease: A systematic review and meta-analysis. Respiratory Investigation 60:1, pages 108-118.
Crossref
Crossref
Yu-Luan Chen, Weimin Wang, Lei Shi & John Eddy. (2021) An ultrasensitive LC–MS/MS method and application to clinical dose-range finding for glycopyrrolate via an e-Nebulizer. Bioanalysis 13:12, pages 959-968.
Crossref
Crossref
Sahar Zayed, Fatma Fouad & Fathalla Belal. (2020) A simple and economic chromatographic method for simultaneous determination of six bronchodilator drugs in pharmaceutical dosage forms. Journal of the Iranian Chemical Society 18:6, pages 1251-1259.
Crossref
Crossref
Ruxandra Ulmeanu, Ariadna Petronela Fildan, Ruxandra Mioara Rajnoveanu, Ovidiu Fira-Mladinescu, Claudia Toma, Roxana Maria Nemes, Emanuela Tudorache, Cristian Oancea & Florin Mihaltan. (2020) Romanian clinical guideline for diagnosis and treatment of COPD. Journal of International Medical Research 48:8, pages 030006052094690.
Crossref
Crossref
Sahar Zayed & Fathalla Belal. (2020) Capillary electrophoresis with field-amplified sample stacking for simultaneous determination of indacaterol and glycopyrronium in inhaler capsules: Application to human plasma and urine. Microchemical Journal 155, pages 104779.
Crossref
Crossref
Yomna A. Salem, Mohammed E.A. Hammouda, Noha M. Saleh, Mohamed A. Abu El-Enin & Saadia M. El-Ashry. (2018) Validated ion pair chromatographic method for simultaneous determination and in vitro dissolution studies of indacaterol and glycopyrronium from inhaled capsule dosage form. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 204, pages 464-474.
Crossref
Crossref
Alena Randáková, Vladimír Rudajev, Vladimír Doležal, John Boulos & Jan Jakubík. (2018) Novel long-acting antagonists of muscarinic ACh receptors. British Journal of Pharmacology 175:10, pages 1731-1743.
Crossref
Crossref
Natalia V. Sharova, D. V. Cherkashin, C. L. Grishaev, G. G. Kutelev & A. V. Chumakov. (2018) The values of the modified
bronchodilation test glycopyrronium to identify the reversibility of bronchial obstruction in patients with chronic obstructive pulmonary disease.. Clinical Medicine (Russian Journal) 96:2, pages 158-163.
Crossref
Crossref
Sahar Zayed & Fathalla Belal. (2017) Rapid simultaneous determination of indacaterol maleate and glycopyrronium bromide in inhaler capsules using a validated stability-indicating monolithic LC method. Chemistry Central Journal 11:1.
Crossref
Crossref
S. N. Avdeev. (2016) PREVENTION OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. PULMONOLOGIYA 26:5, pages 591-603.
Crossref
Crossref
K. Suresh Babu & Jaymin B. Morjaria. (2015) Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary disease. Therapeutic Advances in Respiratory Disease 9:2, pages 56-68.
Crossref
Crossref
Hannu Kankaanranta, Terttu Harju, Maritta Kilpeläinen, Witold Mazur, Juho T. Lehto, Milla Katajisto, Timo Peisa, Tuula Meinander & Lauri Lehtimäki. (2015) Diagnosis and Pharmacotherapy of Stable Chronic Obstructive Pulmonary Disease: The Finnish Guidelines. Basic & Clinical Pharmacology & Toxicology 116:4, pages 291-307.
Crossref
Crossref
Yuji Oba & Nazir A. Lone. (2015) Comparative efficacy of long-acting muscarinic antagonists in preventing COPD exacerbations: a network meta-analysis and meta-regression. Therapeutic Advances in Respiratory Disease 9:1, pages 3-15.
Crossref
Crossref
Adrian Gillissen. (2014) Frischer Wind für COPD-geplagte Lungen. MMW - Fortschritte der Medizin 156:14, pages 68-72.
Crossref
Crossref
Pere Josep Simonet Aineto & Mercè Marzo Castillejo. (2014) Evidencias de los nuevos medicamentos para la enfermedad pulmonar obstructiva crónica. FMC - Formación Médica Continuada en Atención Primaria 21:6, pages 347-354.
Crossref
Crossref
Khuder Alagha, Alain Palot, Tunde Sofalvi, Laurie Pahus, Marion Gouitaa, Celine Tummino, Stephanie Martinez, Denis Charpin, Arnaud Bourdin & Pascal Chanez. (2014) Long-acting muscarinic receptor antagonists for the treatment of chronic airway diseases. Therapeutic Advances in Chronic Disease 5:2, pages 85-98.
Crossref
Crossref
Alexander G. Mathioudakis, Victoria Chatzimavridou-Grigoriadou & Georgios A. Mathioudakis. 2014. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions
241
256
.
Katherine A. Lyseng-Williamson & Natalie J. Carter. (2013) Inhaled glycopyrronium bromide: a guide to its use in moderate to severe chronic obstructive pulmonary disease. Drugs & Therapy Perspectives 29:12, pages 367-372.
Crossref
Crossref
Natalie J. Carter. (2013) Inhaled Glycopyrronium Bromide: A Review of its Use in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease. Drugs 73:7, pages 741-753.
Crossref
Crossref
Debra J. ReidNga T. Pham. (2013) Emerging Therapeutic Options for the Management of COPD. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 7, pages CCRPM.S8140.
Crossref
Crossref